NPI: 1285932475 · PHILADELPHIA, PA 19104 · 261QE0700X
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 8,828 | $16K |
| 2019 | 17 | $0.00 |
| 2020 | 2,534 | $143K |
| 2021 | 7,114 | $390K |
| 2023 | 1,140 | $84K |
| 2024 | 544 | $0.00 |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | 6,090 | 497 | $393K | |
| 90945 | 6,916 | 250 | $235K | |
| Q4081 | Epoetin alfa, 100 units esrd | 2,179 | 214 | $6K |
| G0008 | Admin influenza virus vac | 17 | 16 | $57.84 |
| 90674 | 15 | 14 | $29.23 | |
| 83970 | 393 | 351 | $0.00 | |
| J0887 | Epoetin beta esrd use | 404 | 288 | $0.00 |
| 85041 | 372 | 331 | $0.00 | |
| 85048 | 376 | 334 | $0.00 | |
| J1756 | Iron sucrose injection | 494 | 142 | $0.00 |
| 83540 | 459 | 411 | $0.00 | |
| 82947 | 12 | 12 | $0.00 | |
| 82108 | 24 | 16 | $0.00 | |
| 83550 | 459 | 411 | $0.00 | |
| 82728 | 432 | 394 | $0.00 | |
| A4657 | Syringe w/wo needle | 694 | 397 | $0.00 |
| J1270 | Injection, doxercalciferol | 815 | 70 | $0.00 |
| G0499 | Hepb screen high risk indiv | 26 | 19 | $0.00 |